Ashurst advised BNP Paribas on the arrangement of a €400 million financing to support the acquisition of Amplitude Surgical, a company listed on Euronext Paris and controlled by PAI Partners, by Zydus Lifesciences Ltd (Zydus). This financing, arranged, presented, and guaranteed by BNP Paribas, enabled Zydus to pursue its growth strategy and strengthen its position as a leader in the medical and pharmaceutical sectors. The €400 million credit facility was finalized at the end of July 2025, and the opening of the public tender offer was approved by the French Financial Markets Authority (AMF) on 25 September 2025, confirming the compliance of the simplified public tender offer, which may be followed by a squeeze-out if the conditions are met.
The Ashurst team was led in Paris by Éric Fiszelson, partner, assisted by Jeffrey Andrélan and Adriana Cristiani, associates, in the Global Loan department, as well as Nicolas Bombrun, partner, Gaspard Bastien-Thiry, counsel, and Athénaïs de Sercey, associate, in the Corporate department.
